Narayana Hrudayalaya Ltd logo

Narayana Hrudayalaya Ltd

NH NSE

Narayana Hrudayalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations.[1]

AI Verdict: BUY Confidence: 7%

Narayana Hrudayalaya offers strong growth credentials with 25% 3-year ROE and 20% sales CAGR over 3 years, backed by 90% analyst buy ratings. However, the stock trades at a demanding 47.4x PE and 8.41x book value, warranting caution on entry timing.

Key Fundamentals

MidcapHospitalsHealthcare Services
Market Cap
₹40,235 Cr
Volatility
Moderate
P/E Ratio
49.64
EBITDA
₹1,556 Cr
Return on Equity
27.37%
Debt to Equity
0.62
Book Value
₹222.02
EPS
₹39.47
52W High
₹2,370.2
52W Low
₹1,589

Technical Indicators

Key Insights

Strengths

2
  • Company is expected to give good quarter
  • Company has a good return on equity (ROE) track record: 3 Years ROE 24.7%

Weaknesses

2
  • Stock is trading at 8.82 times its book value
  • Company might be capitalizing the interest cost

Growth Rate

Revenue Growth
41.63% ↗
Net Income Growth
-0.26% ↘
Cash Flow Change
-7.58% ↘
ROE
-20.08% ↘
ROCE
-17.99% ↘
EBITDA Margin (Avg.)
-20.77% ↘

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 3d ago
BUY
Risk medium

Narayana Hrudayalaya offers strong growth credentials with 25% 3-year ROE and 20% sales CAGR over 3 years, backed by 90% analyst buy ratings. However, the stock trades at a demanding 47.4x PE and 8.41x book value, warranting caution on entry timing.

Bull Case 8
  • Exceptional ROE consistency at 25% over 3 years and 26% over 5 years, indicating superior capital efficiency in the hospital sector
  • Revenue growth of 44% TTM and 20% CAGR over 3 years demonstrates strong demand and capacity utilization
  • Overwhelming analyst consensus with 90% buy ratings (9 out of 10 analysts) signals institutional confidence
  • 5-year compounded profit growth of 155% reflects massive operating leverage as hospitals mature
  • 10-year sales CAGR of 17% shows sustained long-term growth trajectory across cycles
  • Stock CAGR of 31% over 5 years and 23% over 3 years validates consistent wealth creation
  • Market cap of Rs 38,103 Cr positions NH as a mid-large cap with further re-rating potential as healthcare sector premiums expand
  • Company is expected to deliver a good quarter, suggesting near-term earnings momentum remains intact
Bear Case 8
  • PE ratio of 47.4x is significantly above the Nifty average of ~22x, leaving limited margin of safety
  • Price-to-book of 8.41x is expensive even by hospital sector standards, pricing in years of future growth
  • 1-year stock CAGR of -1% indicates the stock has stalled, suggesting current valuations may be a ceiling
  • TTM profit growth of only 8% versus 44% revenue growth signals margin compression or rising costs
  • Dividend yield of just 0.24% offers negligible income support during any price correction
  • Potential interest cost capitalization as flagged in concerns raises questions about true profitability and debt servicing transparency
  • 3-year profit CAGR of only 12% lags behind the 20% sales CAGR, suggesting operating leverage benefits may be fading
  • 52-week high and low data unavailable, limiting visibility on current price position within its trading range

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 14h ago
Positives 3
  • ₹4.50 dividend recommended for FY26 Jun 24

    Board recommended ₹4.50 per share dividend for FY26, pending AGM approval on August 14, 2026. Record date set for July 17, 2026.

  • Bullish inverse H&S breakout May 26

    Stock broke out from inverse head & shoulder pattern on daily charts with a short-term target above ₹2,100. Accumulation recommended in ₹1,900-₹1,920 range with support at ₹1,820-₹1,840.

  • Active institutional investor engagement Jun 22

    Company scheduled multiple investor meetings — physical meeting on June 26 with wealth advisors and a virtual meeting on June 10 with mutual funds and insurance companies organized by Choice Equity Broking.

Neutral 1
  • Q4FY26 earnings call audio posted May 26

    Audio recording of Q4 and full-year FY26 earnings call (year ended March 31, 2026) uploaded to company website.

TL;DR: Narayana Hrudayalaya is in a steady phase with no visible operational headwinds. The ₹4.50 dividend signals confidence in cash flows, while the technical breakout pattern and active institutional engagement suggest building momentum. The trend appears constructive with the stock forming higher lows, though sustaining levels above ₹2,100 will be key to confirming the bullish setup.

Quarterly Results

  Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales
1,222
1,233
1,305
1,204
1,246
1,306
1,367
1,335
1,475
1,507
1,644
2,151
2,594
Expenses
946
963
997
925
955
1,004
1,058
1,027
1,118
1,171
1,243
1,786
2,086
Operating Profit
276
271
308
279
291
302
309
307
358
337
401
365
508
OPM %
23%
22%
24%
23%
23%
23%
23%
23%
24%
22%
24%
17%
20%
Other Income
15
15
18
18
26
24
23
18
20
24
24
-29
25
Interest
21
21
23
25
28
34
35
37
41
45
42
65
91
Depreciation
56
59
55
63
65
61
65
70
82
84
87
122
154
PBT
214
206
248
209
225
231
232
219
254
232
296
149
288
Tax %
19%
11%
9%
10%
15%
13%
14%
12%
22%
15%
13%
15%
22%
Net Profit
173
184
227
188
191
202
199
193
197
197
258
127
224
EPS in Rs
8.47
9
11.09
9.2
9.33
9.85
9.72
9.44
9.65
9.62
12.64
6.2
10.96
Figures in ₹ Crores

Profit & Loss

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
1,364
1,614
1,878
2,281
2,861
3,128
2,583
3,701
4,525
4,890
5,483
7,896
Expenses
1,236
1,434
1,642
2,064
2,566
2,694
2,394
3,038
3,538
3,722
4,185
6,285
Operating Profit
128
180
236
217
295
434
189
664
987
1,168
1,298
1,611
OPM %
9%
11%
13%
10%
10%
14%
7%
18%
22%
24%
24%
20%
Other Income
6
-19
7
18
16
7
21
26
59
73
80
45
Interest
45
33
28
55
81
94
82
76
84
112
163
244
Depreciation
68
76
80
100
137
186
184
183
210
241
278
448
PBT
21
51
135
80
93
161
-56
430
752
888
936
964
Tax %
71%
59%
39%
36%
37%
26%
-75%
20%
19%
11%
16%
16%
Net Profit
-19
21
83
51
59
119
-14
342
607
790
791
806
EPS in Rs
-0.84
1.04
4.06
2.51
2.9
5.82
-0.7
16.73
29.67
38.62
38.66
39.42
Div. Payout %
0%
0%
0%
0%
35%
17%
0%
6%
8%
10%
12%
11%
Figures in ₹ Crores

Balance Sheet

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
200
204
204
204
204
204
204
204
204
204
204
204
Reserves
568
672
759
831
877
932
916
1,284
1,927
2,679
3,422
4,333
Borrowings
362
258
217
802
813
952
826
723
884
1,627
2,428
5,857
Other Liabilities
241
424
468
692
746
813
833
931
1,155
1,123
1,216
2,080
Total Liabilities
1,371
1,557
1,648
2,529
2,640
2,901
2,779
3,143
4,170
5,633
7,271
12,474
Fixed Assets
913
1,054
1,082
1,848
1,838
2,092
1,961
1,980
2,336
2,651
4,266
7,821
CWIP
20
14
53
35
56
12
20
67
259
514
86
267
Investments
52
87
96
9
17
86
120
132
252
844
1,084
573
Other Assets
385
402
417
637
729
711
678
964
1,323
1,624
1,835
3,813
Total Assets
1,371
1,557
1,648
2,529
2,640
2,901
2,779
3,143
4,170
5,633
7,271
12,474
Figures in ₹ Crores

Cash Flow

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
77
174
219
182
279
443
304
485
1,085
1,067
986
1,621
Investing
-223
-150
-146
-520
-162
-189
-113
-267
-1,176
-1,458
-1,325
-3,700
Financing
140
18
-45
315
-27
-247
-194
-159
88
488
544
2,340
Net Cash Flow
-6
42
28
-22
89
7
-2
59
-4
97
205
262
Free Cash Flow
-15
86
85
-20
129
329
235
235
563
99
-93
753
CFO/OP
78
116
108
100
113
117
133
83
119
99
86
110
Figures in ₹ Crores

Ratios

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
38
34
30
45
34
31
39
43
35
31
37
30
Inventory Days
56
48
45
56
48
35
32
30
31
44
40
37
Days Payable
146
152
173
200
177
177
221
180
224
214
185
248
Cash Conversion Cycle
-51
-70
-98
-100
-95
-111
-150
-108
-158
-138
-108
-181
Working Capital Days
-30
-12
-11
-10
-10
-22
-38
-16
-25
-30
-17
-1
ROCE %
7%
9%
14%
9%
9%
14%
2%
25%
32%
26%
21%
15%

Shareholding Pattern

As of Mar 2026
Promoters 63.27%
Public 10.64%
FIIs 9.98%
DIIs 9.15%
Others 6.95%
Total 99.99%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.85%
63.27%
63.27%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
11.60%
0.00%
10.91%
10.01%
9.68%
9.44%
9.66%
10.46%
10.49%
11.10%
9.98%
DIIs
14.80%
15.55%
16.15%
14.61%
13.76%
13.43%
16.18%
14.58%
14.14%
11.95%
10.89%
9.46%
9.51%
8.23%
7.90%
8.69%
8.52%
8.09%
7.76%
7.91%
9.15%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.01%
0.01%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
4.64%
4.97%
4.85%
5.11%
5.92%
6.87%
5.86%
6.93%
7.10%
7.99%
8.46%
9.04%
10.00%
11.68%
12.13%
11.58%
11.47%
11.18%
11.45%
10.98%
10.64%
Others
16.71%
15.63%
15.14%
16.43%
16.46%
15.85%
14.11%
14.64%
14.90%
16.20%
5.20%
17.65%
5.73%
6.23%
6.43%
6.43%
6.50%
6.42%
6.45%
6.73%
6.95%
No. of Shareholders
0
36,360
44,526
43,565
43,807
52,747
65,173
68,130
75,370
86,631
1,02,994
1,20,506
1,38,052
1,60,686
1,78,356
1,77,792
1,85,787
2,05,639
2,26,480
2,28,123
2,20,561

Documents

1
Concall - May 2017 May 2017
2
Concall - Jan 2018 Jan 2018
3
Concall - Aug 2020 Aug 2020
4
Concall - Nov 2020 Nov 2020
5
Concall - Oct 2025 Oct 2025

Frequently Asked Questions about Narayana Hrudayalaya Ltd

What does Narayana Hrudayalaya Ltd do?
Narayana Hrudayalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations.[1]
Where is Narayana Hrudayalaya Ltd (NH) listed?
Narayana Hrudayalaya Ltd is listed on the Indian stock exchanges. It is listed on NSE: NH and BSE: 539551. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Narayana Hrudayalaya Ltd belong to?
Narayana Hrudayalaya Ltd operates in the Healthcare sector within the Healthcare Services industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Narayana Hrudayalaya Ltd?
Narayana Hrudayalaya Ltd has a market capitalisation of approximately ₹40234.56 Cr. Based on this, it is classified as a Large Cap stock.
What is the PE ratio of Narayana Hrudayalaya Ltd?
The Price-to-Earnings (PE) ratio of Narayana Hrudayalaya Ltd is 49.64. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Narayana Hrudayalaya Ltd?
Over the past 52 weeks, Narayana Hrudayalaya Ltd has traded between a low of ₹1,589 and a high of ₹2,370.2. This range helps investors understand the stock's price volatility and recent trading levels.
Does Narayana Hrudayalaya Ltd pay dividends?
Yes, Narayana Hrudayalaya Ltd has a dividend yield of 0.23%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Narayana Hrudayalaya Ltd?
Narayana Hrudayalaya Ltd has a Return on Equity (ROE) of 27.37%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Narayana Hrudayalaya Ltd on Tapetide?
On Tapetide, you can view Narayana Hrudayalaya Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Narayana Hrudayalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations.[1]

Website narayanahealth.org
CEO Dr. Devi Prasad Shetty M.S.
Employees 11,411
Listed 2016-01-06
Face Value ₹ 10
Issued Size 20,43,60,804

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List